Nucleus Software: Board Approves FY26 Results, Reappoints MD, Recommends Dividend
Nucleus Software's Board approved FY26 audited results and recommended a final dividend of ₹12.50 per share. Mr. Vishnu R Dusad was re-appointed as Managing Director for five years from January 1, 2027. Amendments to the Whistle Blower Policy were also approved.
The re-appointment of the Managing Director for a long term and the dividend recommendation are significant for stakeholder confidence and future planning, but the financial results themselves are routine.
The approval of financial results, recommendation of a dividend, and re-appointment of a key executive are positive developments for the company.
Nucleus Software Exports Limited announced the outcome of its Board Meeting held on May 21, 2026. The Board approved the Audited Standalone and Unaudited Consolidated Financial Results for the Quarter ended March 31, 2026, as well as the Audited Standalone and Audited Consolidated Financial Results for the Financial Year ended March 31, 2026. The Audit Committee had previously reviewed these financials.
Furthermore, the Board recommended a final dividend of ₹12.50 per equity share (125% of face value) for the financial year 2025-26, subject to shareholder approval at the upcoming Annual General Meeting (AGM).
In a significant move, the Board approved the re-appointment of Mr. Vishnu R Dusad as the Managing Director for a term of five years, effective from January 01, 2027, to December 31, 2031. This re-appointment is also subject to shareholder approval. Mr. Dusad, a founder of the company, has been serving as Managing Director since January 1997 and holds a B.Tech from IIT Delhi.
The Board also considered and approved amendments to the Whistle Blower Policy. The meeting commenced at 10:00 AM and concluded at 2:50 PM. The company's Chief Financial Officer, Mr. Ashok Kumar Bhura, declared that the statutory auditors, ASA & Associates LLP, issued an audit report with an unmodified opinion on the Annual Audited Financial Results (Standalone & Consolidated) for the year ended March 31, 2026.
What to do with a filing like this
Nucleus Software Exports Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Nucleus Software Exports Limited. Read the original for the full detail.